Robert Copeland
Impact in
-
- Neurotransmitter Receptor Influence on Behavior
- Neuroscience and Neuropharmacology Research
- Biological Psychiatry top 10%
- Tryptophan and brain disorders
Papers in
-
- Bioactive Compounds and Antitumor Agents 7
-
- Olfactory and Sensory Function Studies 5
- Co-authors
- Yousef TizabiRobert E. TaylorYasmine KanaanBruk GetachewLi BaiDesta BeyeneS.N. PradhanAntonei B. Csòka
- Journals
- Pharmacology Biochemistry and Behavior (6 papers)Neurotoxicity Research (5 papers)Alcoholism Clinical and Experimental Research (3 papers)Cancer Genomics & Proteomics (3 papers)Neuropharmacology (3 papers)
- Partner nations
- United StatesPolandSouth Korea
In The Last Decade
Robert Copeland
56 papers receiving 891 citations
Peers
Comparison fields: 5 of 102
- Cellular and Molecular Neuroscience 313
- Biological Psychiatry 40
- Toxicology 52
- Molecular Biology 496
- Cancer Research 99
Countries citing papers authored by Robert Copeland
This map shows the geographic impact of Robert Copeland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Copeland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Copeland more than expected).
Fields of papers citing papers by Robert Copeland
This network shows the impact of papers produced by Robert Copeland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Copeland. The network helps show where Robert Copeland may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Robert Copeland, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2023 | 8 | |
| 3 | 2022 | 4 | |
| 4 | 2022 | 6 | |
| 5 | 2022 | 1 | |
| 6 | 2021 | 9 | |
| 7 | 2021 | 11 | |
| 8 | 2021 | 20 | |
| 9 | 2020 | 40 | |
| 10 | 2019 | 20 | |
| 11 | 2017 | 9 | |
| 12 | Antiproliferative activities of Fagara xanthoxyloides and Pseudocedrela kotschyi against prostate cancer cell lines. | 2015 | 12 |
| 13 | 2011 | 15 | |
| 14 | Biochemical characterization of GSK461364: A novel, potent, and selective inhibitor of Polo-like kinase-1 (Plk1) | 2007 | 4 |
| 15 | 2007 | 94 | |
| 16 | 2005 | 37 | |
| 17 | 1994 | 5 | |
| 18 | 1989 | 12 | |
| 19 | 1989 | 12 | |
| 20 | 1988 | 3 |
About Robert Copeland
Robert Copeland is a scholar working on Toxicology, Sensory Systems, Cellular and Molecular Neuroscience, Biological Psychiatry and Cancer Research, having authored 57 papers that have together received 913 indexed citations. Recurring topics across this work include Neurotransmitter Receptor Influence on Behavior (10 papers), Nicotinic Acetylcholine Receptors Study (8 papers), Bioactive Compounds and Antitumor Agents (7 papers), Neuroscience and Neuropharmacology Research (7 papers), Estrogen and related hormone effects (6 papers), Olfactory and Sensory Function Studies (5 papers), Synthesis and biological activity (4 papers) and Vitamin D Research Studies (4 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (313 citations), Biological Psychiatry (40 citations), Toxicology (52 citations), Molecular Biology (496 citations) and Cancer Research (99 citations). Robert Copeland has collaborated with scholars based in United States, Poland and South Korea. Frequent co-authors include Yousef Tizabi, Robert E. Taylor, Yasmine Kanaan, Bruk Getachew, Li Bai, Desta Beyene, S.N. Pradhan, Antonei B. Csòka, Tammey Naab and Jharna R. Das. Their work appears in journals such as Pharmacology Biochemistry and Behavior, Neurotoxicity Research, Alcoholism Clinical and Experimental Research, Cancer Genomics & Proteomics and Neuropharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.